Tomas J. Heyman - Net Worth and Insider Trading
Tomas J. Heyman Net Worth
The estimated net worth of Tomas J. Heyman is at least $0 dollars as of 2024-11-13. Tomas J. Heyman is the Director of Akero Therapeutics Inc and owns about 0 shares of Akero Therapeutics Inc (AKRO) stock worth over $0. Details can be seen in Tomas J. Heyman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tomas J. Heyman has not made any transactions after 2023-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tomas J. Heyman
Tomas J. Heyman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tomas J. Heyman owns 5 companies in total, including Akero Therapeutics Inc (AKRO) , OptiNose Inc (OPTN) , and Invivyd Inc (IVVD) among others .
Click here to see the complete history of Tomas J. Heyman’s form 4 insider trades.
Insider Ownership Summary of Tomas J. Heyman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AKRO | Akero Therapeutics Inc | 2023-06-16 | director |
OPTN | OptiNose Inc | 2020-12-01 | director |
IVVD | Invivyd Inc | 2022-06-22 | director |
2022-09-15 | director | ||
2023-05-31 | director |
Tomas J. Heyman Latest Holdings Summary
Tomas J. Heyman currently owns a total of 1 stock. Tomas J. Heyman owns 0 shares of Akero Therapeutics Inc (AKRO) as of June 16, 2023, with a value of $0.
Latest Holdings of Tomas J. Heyman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AKRO | Akero Therapeutics Inc | 2023-06-16 | 0 | 32.38 | 0 |
Holding Weightings of Tomas J. Heyman
Tomas J. Heyman Form 4 Trading Tracker
According to the SEC Form 4 filings, Tomas J. Heyman has made a total of 1 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 26,000 shares on June 16, 2023, which brought Tomas J. Heyman around $1 Million.
Insider Trading History of Tomas J. Heyman
- 1
Tomas J. Heyman Trading Performance
Tomas J. Heyman Ownership Network
Ownership Network List of Tomas J. Heyman
Ownership Network Relation of Tomas J. Heyman
Tomas J. Heyman Owned Company Details
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Tomas J. Heyman is the director of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Development Officer Catriona Yale , director & President & CEO Andrew Cheng , and Chief Operating Officer Jonathan Young .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Tomas J. Heyman made 1 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 26,000. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 171,998 shares made by Jonathan Young , a net sale of 150,584 shares made by Catriona Yale , and a net sale of 443,502 shares made by Andrew Cheng .
In summary, during the past 3 months, insiders sold 488,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 488,023 shares. During the past 18 months, 1,237,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 82,237 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
Tomas J. Heyman Mailing Address
Above is the net worth, insider trading, and ownership report for Tomas J. Heyman. You might contact Tomas J. Heyman via mailing address: C/o Akero Therapeutics, Inc., 170 Harbor Way 3rd Floor, South San Francisco Ca 94080.